COMMUNIQUÉS West-GlobeNewswire

-
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
10/07/2025 -
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
10/07/2025 -
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
10/07/2025 -
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
10/07/2025 -
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
10/07/2025 -
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
10/07/2025 -
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
10/07/2025 -
Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
10/07/2025 -
Marble Announces its First Vice President of Sales
10/07/2025 -
Passage Bio Announces 1-for-20 Reverse Stock Split
10/07/2025 -
Diagonal Therapeutics Announces Publication of Data Characterizing the Healthcare System Cost and Impact of Hereditary Hemorrhagic Telangiectasia (HHT) in the American Journal of Hematology
10/07/2025 -
OraSure Launches Novel Blood Collection Device for Proteomic Research
10/07/2025 -
AMN Healthcare to Hold Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025
10/07/2025 -
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
10/07/2025 -
BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient
10/07/2025 -
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
10/07/2025 -
Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease
10/07/2025 -
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
10/07/2025 -
Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
10/07/2025
Pages